Current seasonal influenza vaccines, which mainly target hemagglutinin (HA), require
annual updates due to the continuous antigenic drift of the influenza virus. Developing an …

We detected high titers of cross-reactive neuraminidase inhibition antibodies to influenza A
(H5N1) virus clade 2.3. 4.4 b in 96.8%(61/63) of serum samples from healthy adults in Hong …

Influenza virus hemagglutinin mediates infection by binding sialic acids, whereas
neuraminidase cleaves sialic acids to release progeny virions. Both are targets of protective …

Supplementing influenza vaccines with additional protective antigens such as
neuraminidase (NA) is a promising strategy for increasing the breadth of the immune …

Humans experience many influenza infections over their lives, resulting in complex and
varied immunological histories. Although experimental and quantitative analyses have …